Literature DB >> 33465930

Graphene Quantum Dot/Silver Nanoparticle Hybrids with Oxidase Activities for Antibacterial Application.

Shuai Chen1,2, Yue Quan2, Yong-Liang Yu2, Jian-Hua Wang2.   

Abstract

We report the first attempt of using graphene quantum dot-Ag nanoparticles (GQD/AgNP hybrids) as oxidase mimics and antibacterial agents. Unlike previous silver- and graphene-based materials, the GQD/AgNP hybrids exhibit a high oxidase-like catalytic activity and possess favorable stability in neutral medium within the range from room temperature to 60 °C. In accordance with their prominent enzyme activities, the GQD/AgNP hybrids show excellent antibacterial properties against Gram-negative and Gram-positive bacteria as well as drug resistant bacteria, with an ultralow minimal inhibitory concentration (2-4 μg/mL) against 1 × 107 to 1 × 108 μg/mL Escherichia coli and Staphylococcus aureus. In the presence of the GQD/AgNP hybrids, the fluorescence behavior after the introduction of 2', 7'-dichlorofluorescin diacetate demonstrated a possible role of reactive oxidative species in the GQD/AgNP hybrid-mediated antibacterial therapeutic effect. Furthermore, TEM and SEM imaging identified concomitant disruption of the bacterial cell membrane and loss of barrier function during the sterilization process. Therefore, the GQD/AgNP hybrids exhibit vast potentials for serving as highly effective, broad-spectrum antibacterial agent for sterilization use without the need of additional stimulation by laser irradiation (photosensitization) or the provision of H2O2, facilitating their relative ease of use and cost-effectiveness.

Entities:  

Keywords:  Ag nanoparticle; antibacterial effect; graphene quantum dot; oxidase mimic; reactive oxidative species

Year:  2017        PMID: 33465930     DOI: 10.1021/acsbiomaterials.6b00644

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  7 in total

Review 1.  Recent Trends in Composite Nanozymes and Their Pro-Oxidative Role in Therapeutics.

Authors:  Shilpa Maddheshiya; Seema Nara
Journal:  Front Bioeng Biotechnol       Date:  2022-05-30

2.  β-Cyclodextrin-Stabilized Biosynthesis Nanozyme for Dual Enzyme Mimicking and Fenton Reaction with a High Potential Anticancer Agent.

Authors:  Salim Ali; Suranjan Sikdar; Shatarupa Basak; Biplab Rajbanshi; Modhusudan Mondal; Debadrita Roy; Ankita Dutta; Anoop Kumar; Vikas Kumar Dakua; Rinku Chakrabarty; Ashim Roy; Abhinath Barman; Anupam Datta; Pijush K Roy; Bhaskar Chakraborty; Mahendra Nath Roy
Journal:  ACS Omega       Date:  2022-01-28

3.  Silver nanoparticle@carbon quantum dot composite as an antibacterial agent.

Authors:  Tianyu Liu; Qianyue Pang; Kang Mai; Xiaoting He; Li Xu; Feiyan Zhou; Yi Liu
Journal:  RSC Adv       Date:  2022-03-28       Impact factor: 3.361

4.  Colorimetric sensing of chlorpyrifos through negative feedback inhibition of the catalytic activity of silver phosphate oxygenase nanozymes.

Authors:  Amisha Kushwaha; Gajendar Singh; Manu Sharma
Journal:  RSC Adv       Date:  2020-04-01       Impact factor: 4.036

Review 5.  Carbon and graphene quantum dots: a review on syntheses, characterization, biological and sensing applications for neurotransmitter determination.

Authors:  Somayeh Tajik; Zahra Dourandish; Kaiqiang Zhang; Hadi Beitollahi; Quyet Van Le; Ho Won Jang; Mohammadreza Shokouhimehr
Journal:  RSC Adv       Date:  2020-04-20       Impact factor: 4.036

Review 6.  Nanozyme-based catalytic theranostics.

Authors:  Yanan Zhang; Yiliang Jin; Haixia Cui; Xiyun Yan; Kelong Fan
Journal:  RSC Adv       Date:  2019-12-23       Impact factor: 4.036

7.  Silver Covalently Bound to Cyanographene Overcomes Bacterial Resistance to Silver Nanoparticles and Antibiotics.

Authors:  David Panáček; Lucie Hochvaldová; Aristides Bakandritsos; Tomáš Malina; Michal Langer; Jan Belza; Jana Martincová; Renata Večeřová; Petr Lazar; Kateřina Poláková; Jan Kolařík; Lucie Válková; Milan Kolář; Michal Otyepka; Aleš Panáček; Radek Zbořil
Journal:  Adv Sci (Weinh)       Date:  2021-05-03       Impact factor: 16.806

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.